See what others are saying about Doody's Core Titles®
Core Title Selection Process
Contributing Selectors and Others
eBook Aggregator Partners
History and Background
Frequently Asked Questions
Other Doody's Services
Privacy Statement
Additional Products and Services for Libraries
DCT 2023 is coming! This essential collection development tool for health sciences libraries of all sizes represents the collective wisdom of over 200 medical librarians and content experts on the must-have titles in 121 specialties.

You may preorder the 2023 edition of Doody's Core Titles, scheduled to be published on 4/18/2023, by clicking here.

eBook/Digital Version available from:
Web Site

AHFS Drug Information 2023
ISBN: 978-1-58528-706-2, 3479 pages, Soft Cover
ISBN-10: 1-58528-706-7
View Large Size
Copyright: 2023
Edition: 1st
Author: ASHP
Specialties: Pharmacy
Publisher: ASHP
4500 East West Highway
Bethesda, MD 20814
P: 866-279-0681
List Price: $468.00
Checking for Limited Preview at Google

View Citation Citation

At A Glance

AHFS Drug Information 2023 contains the most dependable drug information available - all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.

Updates in the new edition:

  • Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
  • The latest information on COVID-19 vaccines and therapeutics, including information from FDA Emergency Use Authorizations (EUAs), clinical considerations from the US Centers for Disease Control and Prevention (CDC), and guidelines from the Infectious Diseases Society of America (IDSA) and the National Institutes of Health (NIH)
  • Contemporary topics such as new antimigraine treatments, specialty pharmacy drugs, and the antiviral used for treatment of Mpox
  • Inclusion of Standardize4Safety concentration standards for IV and oral liquid drugs
  • Newly published information on breakthrough oncology drugs approved as part of the FDA?s accelerated approval program
  • Expanded content on off-label uses, real-world data, and long-term clinical data
  • Updated information on pharmacogenomic considerations based on recommendations from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
  • Addition of 21 new molecular entities (NMEs) or new therapeutic biological products approved since January 2022

Learn more and order here.

We regularly update the Doody's Core Titles® web site when eBook versions, reviews, or information about forthcoming or new editions of titles in DCT 2022. This month we feature:
  • 374 new eBooks
  • 5 new Reviews (Premium Subscribers Only)

Just Published! Doody's Core Titles® 2022 is available today!

Log in or Order Now to access the full Doody's Core Titles® list.
Doody's Core Titles® 2022
Key Features
A newly selected list of the most distinguished references by subject area
eBook Links to eBook aggregators that carry digital versions
Free monthly Newsletter about new eBooks, new editions, and valuable industry news
Expert recommend-ations of Core Titles and Essential Purchase picks in 121 specialties
Extensive search and filter utilities
Easy-to-use export and print tools
Click here to read what Collection Development Librarians say about Doody's Core Titles®.
Sign up for our Free monthly newsletter alerting you to new eBooks and new editions of DCT titles, as well as valuable industry news and insights. DCT Licensees will have a link to all of the features of Doody's Core Titles® from the newsletter.
Interested in sponsorship opportunities for Doody's Core Titles®? Click here to get more information.